2 May 2026 in Lipids in Health and Disease
Background: Residual atherosclerotic cardiovascular disease (ASCVD) risk often remains even after low-density lipoprotein cholesterol (LDL-C) levels have been brought down to target levels. Remnant cholesterol (RC) and inflammation have been increasingly linked to the residual risk. We aimed to investigating whether the discriminative value of RC the ability of RC to discriminate and its claimed interactions with LDL-C are due to a real clinical phenotype or are affected by formula-dependent biases between the Friedewald and Sampson-NIH equations. Methods: We performed a cross-sectional analysis of consecutively tested adults ( n = 3,342) using residual serum samples from routine clinical monitoring. To reduce analytical variability, all lipid profiles were analyzed using a single, dedicated reagent lot. We contrasted risk models with Friedewald-calculated versus Sampson-NIH-calculated LDL-C to assess equation-dependent differences. Lipid parameters, hemoglobin A1c (HbA1c), estimated glomerular filtration rate (eGFR), and C-reactive protein (CRP) were measured. ASCVD was defined using International Classification of Diseases, 10th Edition (ICD-10) codes. Missing covariate data were handled using multiple imputation by chained equations (m = 50), with additional complete-case sensitivity analyses for CRP-related models. To reduce bias, the observed ASCVD status was included as an auxiliary variable; the outcome itself was not imputed. The discriminative performance of nested logistic regression models was assessed through the pooled area under the receiver operating characteristic curve (AUC) and pooled DeLong p-values. Results: The primary clinical focus was the presence of documented pre-existing ASCVD diagnoses, identified in 11.4% of the cohort, while 9.4% of participants met the criteria for atherogenic dyslipidemia (AD). In the primary analysis with Friedewald LDL-C, we detected a statistically significant ( p < 0.001) negative interaction between LDL-C and RC, while logCRP remained an independent correlate in the adjusted model. Interestingly, when we verified this using the more accurate Sampson-NIH equation to minimize the possibility that the result would be solely due to calculation bias, the paradoxical interaction was still statistically significant ( p = 0.003) along with a strong model performance (AUC: 0.729). This indicates that the interaction is not entirely explained by the mathematical artifact of the Friedewald formula, but rather represents a consistent statistical pattern in this cohort. Conclusion: RC adds statistically significant value to risk discrimination. The continuous inverse relationship of LDL-C with high RC identifies a statistical pattern consistent with persistent atherogenic burden despite apparently optimal calculated LDL-C levels. Awareness of this potential suppressor effect may aid in refining risk stratification in tertiary-care settings.
3 April 2026 in Scandinavian Journal of Clinical and Laboratory Investigation
Blood gas analysis remains one of the most indispensable diagnostic tools in critical care, yet increasing automation often obscures its analytical foundations and limitations. This review provides an integrated perspective by tracing the evolution of blood gas testing from the 1952 polio epidemic to contemporary microfluidic biosensor platforms. Core physical principles governing gas behavior are summarized, and the operational mechanisms of potentiometric (pH and pCO2) and amperometric (pO2) sensors are explained alongside the essential role of optical co-oximetry in identifying dyshemoglobinemias. Major sources of pre-analytical error-such as leukocyte larceny, heparin dilution effects, and syringe permeability-are critically examined, emphasizing the need for meticulous sample handling and appropriate temperature correction. Acid-base interpretation frameworks, including the Boston, Copenhagen, and Stewart physicochemical approaches, are compared to highlight their respective clinical utilities. While Henderson-Hasselbalch-based methods support rapid bedside decision-making, the Stewart model provides enhanced diagnostic clarity in complex metabolic disturbances. Understanding sensor limitations and pre-analytical vulnerabilities remains as crucial as interpreting the numerical results themselves. Future integration of artificial intelligence-based decision support and emerging in-vivo monitoring technologies may further improve diagnostic accuracy and therapeutic turnaround time in critical care.
1 December 2025 in American Journal of Clinical Pathology
Objective: To develop and validate a machine learning model for predicting oligoclonal band (OCB) positivity using routine cerebrospinal fluid (CSF) and serum biochemical markers to improve the diagnostic accuracy and efficiency of assessing intrathecal immunoglobulin G (IgG) synthesis. Methods: In this retrospective study (n = 1709), an ensemble model was developed using 8 refined CSF and serum parameters. Combining optimized CatBoost, XGBoost, and LightGBM classifiers, the model was trained and evaluated using a 2-phase workflow, including 5-fold cross-validation and validation on independent internal (n = 342) and external (n = 49) cohorts. Results: The developed ensemble model achieved a receiver operating characteristic–area under the curve (ROC-AUC) of 0.902 on the internal test set, significantly outperforming the conventional IgG index (ROC-AUC, 0.795). At its optimal threshold, the model demonstrated an accuracy of 0.830, with a sensitivity of 0.714 and a specificity of 0.916. On the external validation cohort, it achieved 90% accuracy and 96% sensitivity. Conclusions: A novel machine learning ensemble model accurately predicts OCB positivity using routine laboratory data and demonstrates superior performance compared with the IgG index. This approach represents a significant step in applying artificial intelligence in laboratory medicine, with the potential to enhance diagnostic efficiency. Prospective, multicenter validation is essential for broader clinical implementation.
27 May 2026 in Turkish Journal of Biochemistry
Objectives: Although lithium (Li) remains a first-line treatment for bipolar disorder (BD), its exact mechanisms of action are still heavily debated. Because neurosteroid (NS) dysregulation plays a critical role in psychiatric disorders, this study looked into whether some of lithium’s effects are mediated through altering intracellular NS levels. Methods: We assessed the effects of Li (0.5–25 mM) on SH-SY5Y cell viability over 24–72 h using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and lactate dehydrogenase (LDH) assays. Following this, we measured intracellular NS levels at specific doses and durations via LC-MS/MS. Results: While 0.5–2.5 mM Li treatments preserved cell viability, doses ≥5 mM markedly reduced it (p<0.05). At a 1 mM non-toxic dose (24 h), we noted a significant buildup in pregnenolone, progesterone, 17-OH progesterone, and dehydroepiandrosterone (DHEA) (p<0.05). Conversely, treating cells with 25 mM Li spiked pregnenolone but significantly depleted androstenedione (p<0.05), and it drove up dehydroepiandrosterone sulfate (DHEAS) across all time points. Conclusions: In conclusion, Li distinctly alters neurosteroidogenesis in a dose and time-dependent manner. Although preliminary, these in vitro findings offer remarkable insights, suggesting that NS pathways might mediate lithium’s clinical efficacy, warranting further comprehensive studies.
3 October 2025 in Journal of Laboratory Medicine
Objectives: Ensuring result comparability across identical analyzers is critical in high-throughput clinical laboratories. ISO 15189:2022 emphasizes this requirement (clause 7.3.7.4), particularly for assays with low within-subject biological variation (BV), where reference intervals may be insufficient to detect clinically relevant changes. Methods: This study aimed to implement a practical rule-based approach for evaluating result consistency across identical analyzers using only internal quality control (IQC) data. At Dokuz Eylul University Central Laboratory (DEU-CL), IQC results from two Beckman Coulter AU5800 and two UniCel DxI 800 analyzers were collected over 12 months (May 2022–April 2023). Coefficient of variation (CV) and bias were calculated from the first five consecutive working days of each month. Total error (TE) was computed using the RMS method (TE=Bias + 1.65 × CV) and compared to total allowable error (TEa) limits defined by the EFLM BV database and Rili-BAEK guideline. Results: Among the 20 parameters evaluated, blood urea nitrogen (BUN), C-reactive protein (CRP), direct/total bilirubin, triglycerides, and uric acid consistently met EFLM TEa criteria. In contrast, albumin, creatinine, sodium, and total protein frequently exceeded EFLM limits. Sodium exhibited persistent nonconformities across all months. Most parameters fulfilled Rili-BAEK specifications. Conclusions: The proposed model enables continuous monthly performance assessment of identical analyzers using only routine IQC data. This approach supports ISO 15189:2022 compliance, facilitates early detection of analytical discrepancies, and may serve as an efficient, cost-effective quality assurance tool for high-volume laboratories.